Keith Haney

Keith Haney, Vice President of Development Operations, leads the technology transfer, manufacturing, quality, and project and alliance management teams. Joining Mycogen Corporation in 1992, Mr. Haney performed in roles supporting discovery and process development including multiple agricultural products utilizing Pseudomonas fluorescens to deliver insecticidal proteins. Following the acquisition of Mycogen by The Dow Chemical Company, Mr. Haney developed fermentation processes for internal projects and client programs utilizing the Pelican Expression Technology™ for both industrial and pharmaceutical applications. Subsequently, he has transferred a number of processes into cGMP manufacturing facilities and had the opportunity to lead cross-functional product development teams, including the team which developed Bonsity™, Pelican’s first commercial product. Mr. Haney has contributed to multiple publications and patents and holds a BA in Biological Sciences from the University of California, Santa Barbara.